3–6 Months | 15–18 Months | |||||
---|---|---|---|---|---|---|
HydroCoil (No.) (%) | Bare Platinum (No.) (%) | P | HydroCoil (No.) (%) | Bare Platinum (No.) (%) | P | |
No. of patients with angiographic follow-up | 58 | 55 | – | 54 | 61 | – |
No. of patients with clinical follow-up | 61 | 55 | – | 63 | 64 | – |
Any recurrence | 9 (15.5) | 11 (20.0) | .62 | 18 (33.3) | 17 (27.9) | .55 |
Major recurrence | 7 (12.1) | 4 (7.3) | .53 | 9 (16.7) | 9 (14.8) | .80 |
Retreatment | 1 (1.7) | 2 (3.6) | .61 | 3 (5.6) | 3 (4.9) | 1.0 |
mRS ≤ 2 | 53 (86.9) | 50 (90.9) | .57 | 57 (90.5) | 57 (89.1) | 1.0 |